Curative Biotechnology, Inc. (CUBT)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -2.5 Million USD | 58.34% |
| 2022 | -4.36 Million USD | 11.38% |
| 2021 | -5.15 Million USD | -8.53% |
| 2020 | -4.59 Million USD | -3065434.67% |
| 2019 | -150.00 USD | 0.0% |
| 2018 | -8731.00 USD | 91.67% |
| 2017 | -1800.00 USD | -147.37% |
| 2016 | 3800.00 USD | 105.01% |
| 2015 | 217.96 Thousand USD | -33.07% |
| 2014 | -70.75 Thousand USD | -94.46% |
| 2013 | -31.74 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -681.39 Thousand USD | 39.31% |
| 2024 Q2 | -549.29 Thousand USD | 19.45% |
| 2023 Q1 | -652.85 Thousand USD | 40.67% |
| 2023 FY | - USD | 58.51% |
| 2023 Q4 | -455.81 Thousand USD | 31.48% |
| 2023 Q3 | -665.19 Thousand USD | -986.02% |
| 2023 Q2 | -61.25 Thousand USD | 90.62% |
| 2022 FY | - USD | 11.38% |
| 2022 Q4 | -1.1 Million USD | -2.41% |
| 2022 Q3 | -1.07 Million USD | -11.77% |
| 2022 Q2 | -961.38 Thousand USD | 25.27% |
| 2022 Q1 | -1.28 Million USD | -38.03% |
| 2021 FY | - USD | -8.53% |
| 2021 Q4 | -931.98 Thousand USD | -7.83% |
| 2021 Q2 | -2.58 Million USD | -324.87% |
| 2021 Q1 | -608.58 Thousand USD | 86.65% |
| 2021 Q3 | -864.31 Thousand USD | 66.57% |
| 2020 Q2 | -17.65 Thousand USD | -21.47% |
| 2020 Q1 | -14.53 Thousand USD | -9588.0% |
| 2020 FY | - USD | -3065434.67% |
| 2020 Q4 | -4.55 Million USD | -73601.81% |
| 2020 Q3 | -6187.00 USD | 64.95% |
| 2019 Q4 | -150.00 USD | -15100.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q3 | 1.00 USD | 100.03% |
| 2019 Q2 | -3971.00 USD | 0.0% |
| 2019 Q1 | -3971.00 USD | 0.0% |
| 2018 FY | - USD | 91.67% |
| 2017 FY | - USD | -147.37% |
| 2016 FY | - USD | 105.01% |
| 2015 FY | - USD | -33.07% |
| 2014 FY | - USD | -94.46% |
| 2014 Q1 | -42.7 Thousand USD | -516.63% |
| 2013 Q1 | -14.77 Thousand USD | 0.0% |
| 2013 Q4 | -6926.00 USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 96.478% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 57.801% |
| SQZ Biotechnologies Company | -64.14 Million USD | 96.099% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 85.596% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 102.661% |
| Mesoblast Limited | -62.38 Million USD | 95.99% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -62.883% |
| Genus plc | 73.7 Million USD | 103.395% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 62.158% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | 29.463% |
| Marizyme, Inc. | -34.28 Million USD | 92.702% |
| ContraFect Corporation | -64.99 Million USD | 96.151% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 71.478% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | 44.723% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -78.481% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | 5.388% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -7.666% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -382.961% |
| Accustem Sciences Inc. | -3.74 Million USD | 33.217% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 94.812% |
| EV Biologics, Inc. | -1.26 Million USD | -97.451% |
| Q BioMed Inc. | -617.62 Thousand USD | -305.092% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 170.044% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -295.626% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -9.52% |
| Biomind Labs Inc. | -1.03 Million USD | -141.841% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 125.331% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 65.063% |
| Skye Bioscience, Inc. | -13.54 Million USD | 81.532% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -68.209% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -9907.848% |
| Arch Therapeutics, Inc. | -3.88 Million USD | 35.588% |
| IMV Inc. | -35.52 Million USD | 92.957% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 84.234% |
| GB Sciences, Inc. | -1.41 Million USD | -76.209% |
| Alpha Cognition Inc. | -9.7 Million USD | 74.221% |
| HST Global, Inc. | -5303.00 USD | -47080.124% |
| CSL Limited | 4.78 Billion USD | 100.052% |
| Halberd Corporation | -74.27 Thousand USD | -3268.33% |
| Enzolytics Inc. | -2.12 Million USD | -17.904% |
| Resverlogix Corp. | -11.74 Million USD | 78.692% |
| Affymax, Inc. | -14.29 Million USD | 82.498% |
| SYBLEU INC | -141.57 Thousand USD | -1667.284% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | 18.317% |
| argenx SE | -216.02 Million USD | 98.842% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 95.479% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 305.584% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -66.919% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 760.42% |
| AVAX Technologies, Inc. | -6.11 Million USD | 59.069% |
| Zenith Capital Corp. | -8.6 Million USD | 70.928% |
| Genscript Biotech Corporation | -248.71 Million USD | 98.994% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -14261.759% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -2.269% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -1321.373% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 93.688% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | 13.497% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -139.122% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 37309.429% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -42.969% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -30.249% |
| BioStem Technologies, Inc. | -7.55 Million USD | 66.877% |
| ONE Bio Corp. | 13.61 Million USD | 118.379% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -1281.628% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -21.632% |
| Agentix Corp. | -1.37 Million USD | -82.391% |
| LadRx Corporation | 412.28 Thousand USD | 706.855% |
| Cell Source, Inc. | -4.27 Million USD | 41.441% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -581.323% |
| Regen BioPharma, Inc. | 1.46 Million USD | 270.671% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -167.033% |
| NovAccess Global Inc. | -1.03 Million USD | -141.783% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 128.259% |
| Itoco Inc. | -1.86 Million USD | -33.867% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -559.07% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -124.19% |
| Kadimastem Ltd | -2.62 Million USD | 4.665% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -946.189% |
| CytoDyn Inc. | -18.02 Million USD | 86.123% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -3065.878% |
| Mobile Lads Corp. | -2.24 Million USD | -11.637% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -20359.253% |
| Qrons Inc. | -40.08 Thousand USD | -6142.264% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -415.148% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 574.366% |
| Rebus Holdings, Inc. | -951 Thousand USD | -163.087% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -135.587% |
| International Stem Cell Corporation | 202 Thousand USD | 1338.595% |
| Bioxytran, Inc. | -3.82 Million USD | 34.506% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -4652.967% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -1.626% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 93.025% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -5459.916% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | 8.621% |
| Neutra Corp. | -181.24 Thousand USD | -1280.416% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 87.589% |
| PureTech Health plc | -11.62 Million USD | 78.481% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 87.588% |
| IXICO plc | -707 Thousand USD | -253.884% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 67.444% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 94.825% |
| CSL Limited | 4.73 Billion USD | 100.053% |
| Cellectis S.A. | -92.63 Million USD | 97.299% |